NCT03245229View on ClinicalTrials.gov

A Study in Healthy Male Subjects to Investigate Whether Administration of ACT-132577 Can Affect Rosuvastatin's Fate in the Body (Amount and Time of Presence in the Blood)

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 10, 2017

Primary Completion Date

September 18, 2017

Study Completion Date

September 18, 2017

Conditions
Healthy Subjects
Interventions
DRUG

Aprocitentan

Capsule for oral administration

DRUG

Rosuvastatin

Tablet for oral administration

Trial Locations (1)

32300

Cepha s.r.o, Pilsen

Sponsors
All Listed Sponsors
lead

Idorsia Pharmaceuticals Ltd.

INDUSTRY

NCT03245229 - A Study in Healthy Male Subjects to Investigate Whether Administration of ACT-132577 Can Affect Rosuvastatin's Fate in the Body (Amount and Time of Presence in the Blood) | Biotech Hunter | Biotech Hunter